261 related articles for article (PubMed ID: 32518601)
1. [Use of lactic acid bacteria as mucosal vaccines].
Bermúdez-Humarán LG; Langella P
Rev Francoph Lab; 2009 Dec; 2009(417):79-89. PubMed ID: 32518601
[TBL] [Abstract][Full Text] [Related]
2. Use of genetically modified lactic acid bacteria and bifidobacteria as live delivery vectors for human and animal health.
Levit R; Cortes-Perez NG; de Moreno de Leblanc A; Loiseau J; Aucouturier A; Langella P; LeBlanc JG; Bermúdez-Humarán LG
Gut Microbes; 2022; 14(1):2110821. PubMed ID: 35960855
[TBL] [Abstract][Full Text] [Related]
3. Lactococci and lactobacilli as mucosal delivery vectors for therapeutic proteins and DNA vaccines.
Bermúdez-Humarán LG; Kharrat P; Chatel JM; Langella P
Microb Cell Fact; 2011 Aug; 10 Suppl 1(Suppl 1):S4. PubMed ID: 21995317
[TBL] [Abstract][Full Text] [Related]
4. Engineering lactococci and lactobacilli for human health.
Bermúdez-Humarán LG; Aubry C; Motta JP; Deraison C; Steidler L; Vergnolle N; Chatel JM; Langella P
Curr Opin Microbiol; 2013 Jun; 16(3):278-83. PubMed ID: 23850097
[TBL] [Abstract][Full Text] [Related]
5. Lactic acid bacteria--20 years exploring their potential as live vectors for mucosal vaccination.
Wyszyńska A; Kobierecka P; Bardowski J; Jagusztyn-Krynicka EK
Appl Microbiol Biotechnol; 2015 Apr; 99(7):2967-77. PubMed ID: 25750046
[TBL] [Abstract][Full Text] [Related]
6. Recombinant lactic acid bacteria as delivery vectors of heterologous antigens: the future of vaccination?
Trombert A
Benef Microbes; 2015; 6(3):313-24. PubMed ID: 25245573
[TBL] [Abstract][Full Text] [Related]
7. Lactic acid bacteria as mucosal delivery vehicles: a realistic therapeutic option.
Wang M; Gao Z; Zhang Y; Pan L
Appl Microbiol Biotechnol; 2016 Jul; 100(13):5691-701. PubMed ID: 27154346
[TBL] [Abstract][Full Text] [Related]
8. Recombinant lactic acid bacteria as promising vectors for mucosal vaccination.
Qiao N; Du G; Zhong X; Sun X
Exploration (Beijing); 2021 Oct; 1(2):20210026. PubMed ID: 37323212
[TBL] [Abstract][Full Text] [Related]
9. Lactic acid bacteria - promising vaccine vectors: possibilities, limitations, doubts.
Szatraj K; Szczepankowska AK; Chmielewska-Jeznach M
J Appl Microbiol; 2017 Aug; 123(2):325-339. PubMed ID: 28295939
[TBL] [Abstract][Full Text] [Related]
10.
Azizpour M; Hosseini SD; Jafari P; Akbary N
Avicenna J Med Biotechnol; 2017; 9(4):163-168. PubMed ID: 29090064
[TBL] [Abstract][Full Text] [Related]
11. Mucosal targeting of therapeutic molecules using genetically modified lactic acid bacteria: an update.
LeBlanc JG; Aubry C; Cortes-Perez NG; de Moreno de LeBlanc A; Vergnolle N; Langella P; Azevedo V; Chatel JM; Miyoshi A; Bermúdez-Humarán LG
FEMS Microbiol Lett; 2013 Jul; 344(1):1-9. PubMed ID: 23600579
[TBL] [Abstract][Full Text] [Related]
12. Heterologous protein production and delivery systems for Lactococcus lactis.
Nouaille S; Ribeiro LA; Miyoshi A; Pontes D; Le Loir Y; Oliveira SC; Langella P; Azevedo V
Genet Mol Res; 2003 Mar; 2(1):102-11. PubMed ID: 12917806
[TBL] [Abstract][Full Text] [Related]
13. Lactococcus lactis as a live vector for mucosal delivery of therapeutic proteins.
Bermúdez-Humarán LG
Hum Vaccin; 2009 Apr; 5(4):264-7. PubMed ID: 19202351
[TBL] [Abstract][Full Text] [Related]
14. Stimulation of cadaverine production by foodborne pathogens in the presence of Lactobacillus, Lactococcus, and Streptococcus spp.
Kuley E; Balıkcı E; Özoğul I; Gökdogan S; Ozoğul F
J Food Sci; 2012 Dec; 77(12):M650-8. PubMed ID: 22853653
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant Strategies for Lactic Acid Bacterial Mucosal Vaccines.
Vilander AC; Dean GA
Vaccines (Basel); 2019 Oct; 7(4):. PubMed ID: 31623188
[TBL] [Abstract][Full Text] [Related]
16. Update on antibiotic resistance in foodborne Lactobacillus and Lactococcus species.
Devirgiliis C; Zinno P; Perozzi G
Front Microbiol; 2013 Oct; 4():301. PubMed ID: 24115946
[TBL] [Abstract][Full Text] [Related]
17. Dominant lactic acid bacteria and their technological properties isolated from the Himalayan ethnic fermented milk products.
Dewan S; Tamang JP
Antonie Van Leeuwenhoek; 2007 Oct; 92(3):343-52. PubMed ID: 17562218
[TBL] [Abstract][Full Text] [Related]
18. Antioxidant and cholesterol assimilation activities of selected lactobacilli and lactococci cultures.
Jain S; Yadav H; Sinha PR
J Dairy Res; 2009 Nov; 76(4):385-91. PubMed ID: 19638266
[TBL] [Abstract][Full Text] [Related]
19. Stress responses in lactic acid bacteria.
van de Guchte M; Serror P; Chervaux C; Smokvina T; Ehrlich SD; Maguin E
Antonie Van Leeuwenhoek; 2002 Aug; 82(1-4):187-216. PubMed ID: 12369188
[TBL] [Abstract][Full Text] [Related]
20. Mucosal vaccination and therapy with genetically modified lactic acid bacteria.
Wells J
Annu Rev Food Sci Technol; 2011; 2():423-45. PubMed ID: 22129390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
